Cour Pharmaceuticals Development

0 followers


Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Industries

+1

Headquarters

Stage

Employees

Links

Org chart

John J. Puisis
Co-Founder & President & CEO

John J. Puisis

Collapse
Dannielle Appelhans
Chief Operating Officer
Adam Elhofy
VP, Immunology & Innovation
Robert Hodge
VP of Technical Development
Pooja Agashe
Intellectual Property and Business Analyst
Sandeep Kakade
Senior Formulations & Product Development Scientist
Jerry Staser
Associate Director, Clinical Operations
Lori Jester
Vice President Of Manufacturing And Supply Chain